Back to top
more

Integra LifeSciences (IART)

(Delayed Data from NSDQ)

$29.11 USD

29.11
531,879

+0.43 (1.48%)

Updated Apr 22, 2024 11:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline

Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Investors Should Retain Integra (IART) Stock Now

Integra's (IART) strong focus on portfolio optimization and international expansion bolsters investors' confidence in the stock.

Why Is Integra (IART) Down 4% Since Last Earnings Report?

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Integra LifeSciences (IART) Introduces MicroMatrix Flex

Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.

Integra's (IART) Q4 Earnings Miss Estimates, Margins Down

Integra's (IART) Q4 revenues are impacted by the decline in the Tissue Technologies segment.

Compared to Estimates, Integra (IART) Q4 Earnings: A Look at Key Metrics

The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Integra LifeSciences (IART) Misses Q4 Earnings and Revenue Estimates

Integra (IART) delivered earnings and revenue surprises of -1.11% and 0.44%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Integra (IART) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

Besides Wall Street's top -and-bottom-line estimates for Integra (IART), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.

Earnings Preview: Integra LifeSciences (IART) Q4 Earnings Expected to Decline

Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Edwards Lifesciences (EW) Q4 Earnings Match Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 0% and 2.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Thermo Fisher Scientific (TMO) Tops Q4 Earnings and Revenue Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 0.53% and 1.40%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Investors Should Retain Integra (IART) Stock Now

Investors remain optimistic about Integra (IART) due to the positive outlook for its CSS segment.

Integra (IART) to Advance ENT Division With New Buyout Deal

Integra (IART) will be among the top suppliers of ENT products and technologies following the Acclarent acquisition.

Integra Gains From New Product Launches, Mounting Costs Ail

Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America.

Why Is Glaukos (GKOS) Down 0.4% Since Last Earnings Report?

Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Integra (IART) Up 10.2% Since Last Earnings Report?

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Integra's (IART) Q3 Earnings Miss Estimates, 2023 View Cut

The impact of lost revenues and an increase in the return provision related to the Boston product recall dent Integra's (IART) Q3 revenues.

Integra (IART) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Integra LifeSciences (IART) Q3 Earnings and Revenues Miss Estimates

Integra (IART) delivered earnings and revenue surprises of -2.56% and 1.35%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

IART vs. IDXX: Which Stock Is the Better Value Option?

IART vs. IDXX: Which Stock Is the Better Value Option?

Here's Why Investors Should Retain Integra (IART) Stock Now

International expansion and the strong prospects of the CSS segment bode well for Integra (IART).

Here's Why You Should Retain Integra (IART) Stock for Now

Investors continue to be optimistic about Integra (IART) based on the prospects of its CSS segment and a stable liquidity position.

Why Is Integra (IART) Down 7.9% Since Last Earnings Report?

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Integra (IART) CSS Sales Aid, Boston Recall Hurts Growth

In spite of facing foreign exchange fluctuations across its non-U.S. business, Integra (IART) is successfully broadening its international footprint.